Walleye Capital’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22K Buy
+2,400
New +$26.8K ﹤0.01% 4368
2025
Q4
Sell
-11,100
Closed -$57.5K 5007
2025
Q3
$57.5K Sell
11,100
-15,900
-59% -$91.4K ﹤0.01% 3957
2025
Q2
$160K Buy
+27,000
New +$163K ﹤0.01% 3526
2025
Q1
Sell
-10,600
Closed -$87.6K 4962
2024
Q4
$87.6K Sell
10,600
-1,200
-10% -$9.63K ﹤0.01% 4189
2024
Q3
$90.3K Buy
11,800
+10,000
+556% +$92.1K ﹤0.01% 4429
2024
Q2
$18.6K Sell
1,800
-4,100
-69% -$45K ﹤0.01% 5127
2024
Q1
$70.4K Buy
+5,900
New +$65.5K ﹤0.01% 4553
2023
Q4
Sell
-700
Closed -$9.69K 5401
2023
Q3
$9.69K Buy
+700
New +$10.2K ﹤0.01% 4488

Other funds holding PTEN

Walleye Capital's PTEN Position: Q2 2026 in Review

Walleye Capital reduced its Patterson-UTI (PTEN) stake by 94% in Q2 2026, selling an estimated $3.29M and leaving 17,223 shares worth $158K. The position accounts for ﹤0.01% of the portfolio, ranked #3638.

Walleye Capital first reported a position in PTEN in Q2 2020 and has held it in 13 quarters since. The position peaked at $13.3M in Q3 2023. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • Walleye Capital held 17,223 shares of Patterson-UTI worth $158K as of Q2 2026.
  • Walleye Capital sold 295,043 Patterson-UTI shares in Q2 2026, an estimated $3.29M.
  • Patterson-UTI made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3638 holding.
  • Walleye Capital first reported a position in Patterson-UTI in Q2 2020 and has held it in 13 quarters since.
  • Walleye Capital's Patterson-UTI position peaked at $13.3M in Q3 2023.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.